Origin Agritech Limited (SEED)
NASDAQ:SEED
Want to see SEED full AI Analyst Report?
SEED Stock Chart & Stats
$1.32
-$0.10(-5.19%)
At close: 4:00 PM EST
$1.32
-$0.10(-5.19%)
Day’s Range― - ―
52-Week Range$0.74 - $2.49
Previous CloseN/A
Volume43.60K
Average Volume (3M)2.25M
Market Cap
$11.98M
Enterprise Value$82.75M
Total Cash (Recent Filing)$15.91M
Total Debt (Recent Filing)$54.27M
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Jan 11, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.09
Shares Outstanding12,143,526
10 Day Avg. Volume6,011,928
30 Day Avg. Volume2,246,586
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-2.76
Price to Sales (P/S)0.71
P/FCF Ratio-1.80
Enterprise Value/Market Cap6.91
Enterprise Value/Revenue1.10
Enterprise Value/Gross Profit10.52
Enterprise Value/Ebitda-3.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Deep R&D And Breeding PipelineA very large, data-rich breeding pipeline and AI-assisted germplasm work represent durable capability to generate new seed varieties. Scale of combinations and germplasm resources raises the odds of repeatable product introductions and licensing opportunities, supporting longer-term revenue potential once commercialized.
Strengthened Biotech & Commercial ReadinessPossession of gene-editing platforms, a biosafety certificate and restored processing capacity are structural assets that materially improve the company's ability to commercialize biotech traits and negotiate partnerships or licensing deals. These credentials reduce technical barriers and increase long-term strategic optionality.
Demonstrated Cost Discipline And Operating LeverageLarge, sustained reductions in overhead alongside targeted S&M and R&D reinvestment show management can shrink fixed costs while prioritizing growth activities. Improved operating loss demonstrates emerging leverage that, if maintained, can materially extend runway and improve profitability as sales scale.
Bears Say
Stressed Balance Sheet And Rising DebtPersistently negative equity combined with a notable 2025 debt increase creates a structurally fragile capital base. This limits financing options, raises refinancing and dilution risk, and constrains the company's ability to invest counter-cyclically or absorb shocks, a durable constraint on strategic flexibility.
Weak And Inconsistent Cash GenerationSustained negative operating and free cash flow implies the business cannot reliably self-fund growth or absorb working-capital swings. Reliance on external capital to cover ongoing losses and inventory builds increases execution risk and may force dilutive financing or spending cuts that impair long-term commercialization plans.
Regulatory & Execution Dependency For GMO UpsideMaterial revenue upside hinges on regulatory approvals and timely execution. Policy timing in China and the company's need to convert pipeline into field sales are structural uncertainties; delays or slower adoption would materially defer returns on R&D investment and weaken the company's path to sustainable profits.
Origin Agritech News
SEED FAQ
What was Origin Agritech Limited’s price range in the past 12 months?
Origin Agritech Limited lowest stock price was $0.74 and its highest was $2.49 in the past 12 months.
What is Origin Agritech Limited’s market cap?
Origin Agritech Limited’s market cap is $11.98M.
When is Origin Agritech Limited’s upcoming earnings report date?
Origin Agritech Limited’s upcoming earnings report date is Jan 11, 2027 which is in 202 days.
How were Origin Agritech Limited’s earnings last quarter?
Origin Agritech Limited released its earnings results on May 21, 2026. The company reported -$0.172 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.172.
Is Origin Agritech Limited overvalued?
According to Wall Street analysts Origin Agritech Limited’s price is currently Overvalued.
Does Origin Agritech Limited pay dividends?
Origin Agritech Limited does not currently pay dividends.
What is Origin Agritech Limited’s EPS estimate?
Origin Agritech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Agritech Limited have?
Origin Agritech Limited has 12,143,526 shares outstanding.
What happened to Origin Agritech Limited’s price movement after its last earnings report?
Origin Agritech Limited reported an EPS of -$0.172 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Origin Agritech Limited?
Currently, no hedge funds are holding shares in SEED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Origin Agritech Limited
Established in 1997 and headquartered in Beijing, China, Origin Agritech Limited is a Chinese firm operating in two primary areas: agricultural biotechnology and an e-commerce platform. Its biotechnology segment focuses on the genetic enhancement and breeding of crop seeds, encompassing the development, production, and distribution of hybrid crop varieties and associated seed technologies. The firm also manages an e-commerce platform that caters to farmers across China, offering a diverse array of goods via online and mobile channels. This selection includes agricultural seeds like corn, rice, and vegetables, along with essential farming inputs such as fertilizers and agricultural chemicals. Additionally, the platform provides food, household items, and other consumer products. Origin Agritech maintains collaboration agreements with esteemed institutions such as the Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University.
SEED Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced view: clear operational and structural progress (large cuts in G&A, improved operating loss, strengthened biotech credentials, rebuilt sales force, sizable breeding pipeline and targeted variety acquisitions) alongside meaningful near-term challenges (a 31.9% revenue decline, ongoing net loss, modest cash position, higher inventories and dependency on regulatory timing for GMO commercialization). Management emphasized that the company is in the midpoint of a recovery plan and investing in sales and R&D to convert pipeline into revenue, but realization of that upside remains contingent on execution and policy developments.View all SEED earnings summariesTechnical Analysis
American Vanguard
―
Arcadia Biosciences
―
BioHarvest Sciences
―
Bioceres Crop Solutions
―
―
Ownership Overview
―
Insiders
0.07% Mutual Funds
0.33% Other Institutional Investors
99.60% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---